Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53(R270H/+)WAPCre mouse model

por ter Braak, Bas, Siezen, Christine, Speksnijder, Ewoud N, Koedoot, Esmee, van Steeg, Harry, Salvatori, Daniela CF, van de Water, Bob, van der Laan, Jan Willem
Publicado 2015

Metabolic activation of 2‐amino‐1‐methyl‐6‐phenylimidazo [4,5‐b]pyridine and DNA adduct formation depends on p53: Studies in T rp53(+/+),T rp53(+/−) and T rp53(−/−) mice...

por Krais, Annette M., Speksnijder, Ewoud N., Melis, Joost P.M., Singh, Rajinder, Caldwell, Anna, Gamboa da Costa, Gonçalo, Luijten, Mirjam, Phillips, David H., Arlt, Volker M.
Publicado 2015

Human TP53 polymorphism (rs1042522) modelled in mouse does not affect glucose metabolism and body composition

por Reiling, Erwin, Speksnijder, Ewoud N., Pronk, Amanda C. M., van den Berg, Sjoerd A. A., Neggers, Silvia J. W., Rietbroek, Ilma, van Steeg, Harry, Dollé, Martijn E. T.
Publicado 2014

The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice

por Krais, Annette M., Speksnijder, Ewoud N., Melis, Joost P. M., Indra, Radek, Moserova, Michaela, Godschalk, Roger W., van Schooten, Frederik-J., Seidel, Albrecht, Kopka, Klaus, Schmeiser, Heinz H., Stiborova, Marie, Phillips, David H., Luijten, Mirjam, Arlt, Volker M.
Publicado 2015